Company research / AQST
Aquestive Therapeutics, Inc. (AQST)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Aquestive Therapeutics, Inc. reported revenue of $44.55M. Revenue fell 22.6% from the prior annual period.
Key ratios (year ended 2025-12-31)
-159.5%
Operating margin
-188.1%
Net margin
-22.6%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.